
Sign up to save your podcasts
Or


In this episode, Dr. Vishnu Sundaresan from our Defense Sciences Office highlights several technology programs designed to precisely control chemical processes to enable distributed, small-batch manufacturing of chemical products while retaining efficiencies of large-scale industrial production. Colloquially calling this portfolio “decentralized chemistry for everything,” the concept aims to shift the paradigm from a few centralized production facilities producing medicines in large batches and requiring a costly purification process, to direct manufacturing of pure pharmaceuticals via desktop printer-sized machines that would create — at the push of a button — doses of a variety of medicines whenever and wherever needed. Such a revolutionary capability — if successful — would circumvent brittle international chemical supply chains and would serve military members deployed in remote locations as well as benefit rural civilian communities.
Sundaresan describes programs aiming to achieve elements of this vision: Spin-COntrolled chemical Process Engineering (SCOPE), Recycling at the Point of Disposal (RPOD), and Establishing Qualification Processes for Agile Pharmaceutical Manufacturing (EQUIP-A-Pharma).
Listen to Sundaresan describe his journey to becoming a DARPA program manager, the fascinating world of controlling electron spins, and the ethical, legal, and societal challenges of preparing the market for such revolutionary tech.
By DARPA4.8
108108 ratings
In this episode, Dr. Vishnu Sundaresan from our Defense Sciences Office highlights several technology programs designed to precisely control chemical processes to enable distributed, small-batch manufacturing of chemical products while retaining efficiencies of large-scale industrial production. Colloquially calling this portfolio “decentralized chemistry for everything,” the concept aims to shift the paradigm from a few centralized production facilities producing medicines in large batches and requiring a costly purification process, to direct manufacturing of pure pharmaceuticals via desktop printer-sized machines that would create — at the push of a button — doses of a variety of medicines whenever and wherever needed. Such a revolutionary capability — if successful — would circumvent brittle international chemical supply chains and would serve military members deployed in remote locations as well as benefit rural civilian communities.
Sundaresan describes programs aiming to achieve elements of this vision: Spin-COntrolled chemical Process Engineering (SCOPE), Recycling at the Point of Disposal (RPOD), and Establishing Qualification Processes for Agile Pharmaceutical Manufacturing (EQUIP-A-Pharma).
Listen to Sundaresan describe his journey to becoming a DARPA program manager, the fascinating world of controlling electron spins, and the ethical, legal, and societal challenges of preparing the market for such revolutionary tech.

43,898 Listeners

14,378 Listeners

153,248 Listeners

766 Listeners

1,657 Listeners

396 Listeners

292 Listeners

821 Listeners

111,948 Listeners

646 Listeners

2,534 Listeners

1,667 Listeners

10,182 Listeners

259 Listeners

15,950 Listeners